Histoacryl (N-butyl-2-cyanoacrylate)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Histoacryl (N-butyl-2-cyanoacrylate), covering 2010-06-08 to 2010-06-08. Get the full timeline:
Most recent: Clinical Trial Update: Endoscopic Cyanoacrylate Obliteration vs. Nadolol Treatment in the Prevention of Gastric Variceal Rebleeding [Phase 4]